Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation

Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaleigh Katzer, Jessica L. Hill, Kara B. McIver, Michelle T. Foster
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/60e60c55367c4b41bb2cc74cf1484691
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:60e60c55367c4b41bb2cc74cf1484691
record_format dspace
spelling oai:doaj.org-article:60e60c55367c4b41bb2cc74cf14846912021-11-11T17:10:49ZLipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation10.3390/ijms2221117201422-00671661-6596https://doaj.org/article/60e60c55367c4b41bb2cc74cf14846912021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11720https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuation, such as puberty, pregnancy, or menopause. Although the identification and characterization of lipedema have improved, the underlying disease etiology remains to be elucidated. Estrogen, a key regulator of adipocyte lipid and glucose metabolism, and female-associated body fat distribution are postulated to play a contributory role in the pathophysiology of lipedema. Dysregulation of adipose tissue accumulation via estrogen signaling likely occurs by two mechanisms: (1). altered adipocyte estrogen receptor distribution (ERα/ERß ratio) and subsequent metabolic signaling and/or (2). increased release of adipocyte-produced steroidogenic enzymes leading to increased paracrine estrogen release. These alterations could result in increased activation of peroxisome proliferator-activated receptor γ (PPARγ), free fatty acid entry into adipocytes, glucose uptake, and angiogenesis while decreasing lipolysis, mitochondriogenesis, and mitochondrial function. Together, these metabolic alterations would lead to increased adipogenesis and adipocyte lipid deposition, resulting in increased adipose depot mass. This review summarizes research characterizing estrogen-mediated adipose tissue metabolism and its possible relation to excessive adipose tissue accumulation associated with lipedema.Kaleigh KatzerJessica L. HillKara B. McIverMichelle T. FosterMDPI AGarticlelipedemaadipose tissueestrogen receptorlipoprotein lipaseGLUT4peroxisome proliferator-activated receptor gammaBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11720, p 11720 (2021)
institution DOAJ
collection DOAJ
language EN
topic lipedema
adipose tissue
estrogen receptor
lipoprotein lipase
GLUT4
peroxisome proliferator-activated receptor gamma
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle lipedema
adipose tissue
estrogen receptor
lipoprotein lipase
GLUT4
peroxisome proliferator-activated receptor gamma
Biology (General)
QH301-705.5
Chemistry
QD1-999
Kaleigh Katzer
Jessica L. Hill
Kara B. McIver
Michelle T. Foster
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
description Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuation, such as puberty, pregnancy, or menopause. Although the identification and characterization of lipedema have improved, the underlying disease etiology remains to be elucidated. Estrogen, a key regulator of adipocyte lipid and glucose metabolism, and female-associated body fat distribution are postulated to play a contributory role in the pathophysiology of lipedema. Dysregulation of adipose tissue accumulation via estrogen signaling likely occurs by two mechanisms: (1). altered adipocyte estrogen receptor distribution (ERα/ERß ratio) and subsequent metabolic signaling and/or (2). increased release of adipocyte-produced steroidogenic enzymes leading to increased paracrine estrogen release. These alterations could result in increased activation of peroxisome proliferator-activated receptor γ (PPARγ), free fatty acid entry into adipocytes, glucose uptake, and angiogenesis while decreasing lipolysis, mitochondriogenesis, and mitochondrial function. Together, these metabolic alterations would lead to increased adipogenesis and adipocyte lipid deposition, resulting in increased adipose depot mass. This review summarizes research characterizing estrogen-mediated adipose tissue metabolism and its possible relation to excessive adipose tissue accumulation associated with lipedema.
format article
author Kaleigh Katzer
Jessica L. Hill
Kara B. McIver
Michelle T. Foster
author_facet Kaleigh Katzer
Jessica L. Hill
Kara B. McIver
Michelle T. Foster
author_sort Kaleigh Katzer
title Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
title_short Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
title_full Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
title_fullStr Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
title_full_unstemmed Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
title_sort lipedema and the potential role of estrogen in excessive adipose tissue accumulation
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/60e60c55367c4b41bb2cc74cf1484691
work_keys_str_mv AT kaleighkatzer lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation
AT jessicalhill lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation
AT karabmciver lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation
AT michelletfoster lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation
_version_ 1718432179674939392